JP5815725B2 - 創傷治癒組成物およびその使用方法 - Google Patents

創傷治癒組成物およびその使用方法 Download PDF

Info

Publication number
JP5815725B2
JP5815725B2 JP2013537646A JP2013537646A JP5815725B2 JP 5815725 B2 JP5815725 B2 JP 5815725B2 JP 2013537646 A JP2013537646 A JP 2013537646A JP 2013537646 A JP2013537646 A JP 2013537646A JP 5815725 B2 JP5815725 B2 JP 5815725B2
Authority
JP
Japan
Prior art keywords
wound
wound healing
healing composition
polypeptide
hsp90α
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013537646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013542954A5 (enExample
JP2013542954A (ja
Inventor
ファン チェン，チ
ファン チェン，チ
ウッドリー，デーヴィッド，ティー．
チェン，メイ
リ，ウェイ
Original Assignee
ユニバーシティ オブ サザン カリフォルニア
ユニバーシティ オブ サザン カリフォルニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ オブ サザン カリフォルニア, ユニバーシティ オブ サザン カリフォルニア filed Critical ユニバーシティ オブ サザン カリフォルニア
Publication of JP2013542954A publication Critical patent/JP2013542954A/ja
Publication of JP2013542954A5 publication Critical patent/JP2013542954A5/ja
Application granted granted Critical
Publication of JP5815725B2 publication Critical patent/JP5815725B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
JP2013537646A 2010-11-03 2010-11-03 創傷治癒組成物およびその使用方法 Active JP5815725B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/055319 WO2012060832A1 (en) 2010-11-03 2010-11-03 Skin wound healing compositions and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2013542954A JP2013542954A (ja) 2013-11-28
JP2013542954A5 JP2013542954A5 (enExample) 2014-01-16
JP5815725B2 true JP5815725B2 (ja) 2015-11-17

Family

ID=46024739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013537646A Active JP5815725B2 (ja) 2010-11-03 2010-11-03 創傷治癒組成物およびその使用方法

Country Status (6)

Country Link
EP (1) EP2635293B1 (enExample)
JP (1) JP5815725B2 (enExample)
CN (1) CN103458914B (enExample)
CA (1) CA2816818C (enExample)
DK (1) DK2635293T3 (enExample)
WO (1) WO2012060832A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207118B2 (en) 2009-07-17 2012-06-26 University Of Southern California Skin wound healing compositions and methods of use thereof
KR102143557B1 (ko) * 2013-08-09 2020-08-12 주식회사 리제론 인간 열 활성화 단백질 90a의 절편을 유효성분으로 포함하는 피부상태 개선용 조성물
US9468654B1 (en) 2014-04-02 2016-10-18 Ali Razavi Drug delivery compositions and methods
US20180201662A1 (en) * 2016-11-30 2018-07-19 Industrial Technology Research Institute Peptide for promoting cell migration and/or skin wound healing, pharmaceutical composition containing the same, and application thereof
CN107446018B (zh) * 2017-08-07 2020-07-17 温州千瑞生物科技有限公司 促进伤口愈合的肽及其应用
WO2022178005A1 (en) 2021-02-17 2022-08-25 Oxion Dental, Llc Stabilized active oxygen-generating antiseptic compositions, irrigation solutions, and articles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183805A (en) * 1990-08-13 1993-02-02 Board Of Regents, The University Of Texas System Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
US6475490B1 (en) * 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
US7081240B1 (en) 2000-06-28 2006-07-25 Zimmer Orthobiologics, Inc. Protein mixtures for wound healing
TWI305778B (en) * 2001-12-03 2009-02-01 Nishida Teruo Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
US20070098735A1 (en) * 2005-10-29 2007-05-03 Chandawarkar Rajiv Y Methods for the Elimination of Pathogens and Other Particulate Agents
KR101020658B1 (ko) * 2006-01-23 2011-03-09 주식회사 이매진 신규한 펩타이드 및 이의 용도
US8022037B2 (en) * 2007-01-08 2011-09-20 University Of Southern California Skin wound healing compositions and methods of use thereof

Also Published As

Publication number Publication date
CN103458914B (zh) 2015-11-25
DK2635293T3 (en) 2018-06-14
EP2635293A4 (en) 2014-04-02
JP2013542954A (ja) 2013-11-28
CN103458914A (zh) 2013-12-18
CA2816818C (en) 2019-01-22
CA2816818A1 (en) 2012-05-10
WO2012060832A1 (en) 2012-05-10
EP2635293B1 (en) 2018-04-04
EP2635293A1 (en) 2013-09-11

Similar Documents

Publication Publication Date Title
US8022037B2 (en) Skin wound healing compositions and methods of use thereof
US8455443B2 (en) Methods of use of skin wound healing compositions
JP5815725B2 (ja) 創傷治癒組成物およびその使用方法
Kant et al. Topical pluronic F-127 gel application enhances cutaneous wound healing in rats
Koca Kutlu et al. A comparison study of growth factor expression following treatment with transcutaneous electrical nerve stimulation, saline solution, Povidone‐iodine, and lavender oil in wounds healing
US8110655B2 (en) Method to promote hair growth and/or delay or treat hair loss by administering a TGF-β antagonist or inhibitor
Johnson et al. Coacervate delivery of HB‐EGF accelerates healing of type 2 diabetic wounds
US5155038A (en) Use of thrombospondin to promote wound healing
Bazrafshan et al. Activation of mitosis and angiogenesis in diabetes-impaired wound healing by processed human amniotic fluid
JP2018529675A (ja) 局所エリスロポエチン製剤および前記製剤を用いて創傷治癒を改善するための方法および前記製剤の美容用途
JP7026050B2 (ja) 慢性創傷を治療するための組成物及び方法
Zhao et al. Sprayable NAHAO® hydrogel alleviates pain and accelerates rat oral mucositis wound healing
EP2244719B1 (en) Wound healing peptides and methods of use thereof
EP3288579A1 (en) A novel skin medical and cosmetic care product
Patil et al. Assessment of healing potential of colostrum against incisional wound model in mice
CN105561292A (zh) 皮肤伤口愈合组合物及其使用方法
Muangman et al. 088 Topical Substance P Modulates Inflammatory Responses in Healing Wounds in Nitric Oxide Synthase Knockout Mice
Gold et al. 145 Biological Effects of Calreticulin on Wound Repair
Roy et al. 106 Lentivirus and Adeno‐Associated Virus Mediated Targeted Gene Transfection in Low‐Oxygen Environment
Philip et al. 148 2‐Methoxyestradiol, an Endogenous Estrogen Metabolite, Regulates Apoptosis in Skin Microvascular Endothelial Cells
Kurt et al. 060 The Effect of Localized Intra‐abdominal Infection on Colon Anastomotic Healing in Rats
Bhat et al. 090 Effect of Cytokines and Heat Shock on Human β‐Defensin‐2 Levels in Cultured Keratinocytes
Han et al. 016 TNF‐alpha Mediated Induction of MMP‐9 is Modulated by P21‐activated Kinase (PAK)
Aslam et al. 049 Lactate Controls Vascular Development in Wound Healing
Lu et al. 045 Adenoviral HTERT Transfection Results in Altered Phospho‐erk Activity in Human Dermal Fibroblasts

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130924

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131031

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141007

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141226

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150811

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150812

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150901

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150924

R150 Certificate of patent or registration of utility model

Ref document number: 5815725

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250